Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020

Description Table of
Contents Companies Mentioned

FEATURED COMPANIES

Aespira Ltd.
Creare LLC
Iconovo AB
Monash University
OtiTopic LLC
Sandoz International GmbH
MORE

Summary

The publisher's Medical Devices sector report, “Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2020“. Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Dry Powder Inhaler Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Dry Powder Inhaler Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

Note: Product cover images may vary from those shown

FEATURED COMPANIES

Aespira Ltd.
Creare LLC
Iconovo AB
Monash University
OtiTopic LLC
Sandoz International GmbH
MORE

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Dry Powder Inhaler Devices Overview

3 Products under Development

3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory
3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials

4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies

4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development

5 Dry Powder Inhaler Devices Companies and Product Overview

5.1 Adamis Pharmaceuticals Corp Company Overview
5.1.1 Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advent Pharmaceuticals Pty Ltd Company Overview
5.2.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aespira Ltd. Company Overview
5.3.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.4 AKELA Pharma Inc. (Inactive) Company Overview
5.4.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 AstraZeneca Plc Company Overview
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bayer AG Company Overview
5.6.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
5.7 Boehringer Ingelheim International GmbH Company Overview
5.7.1 Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.8 Circassia Group Plc Company Overview
5.8.1 Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Creare LLC Company Overview
5.9.1 Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 Eli Lilly and Co Company Overview
5.10.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
5.11 GlaxoSmithKline Plc Company Overview
5.11.1 GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Hovione Technology Ltd Company Overview
5.12.1 Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Iconovo AB Company Overview
5.13.1 Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
5.14 Liquidia Technologies Inc Company Overview
5.14.1 Liquidia Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Lupin Pharmaceuticals Inc Company Overview
5.15.1 Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 MannKind Corp Company Overview
5.16.1 MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 Monash University Company Overview
5.17.1 Monash University Pipeline Products & Ongoing Clinical Trials Overview
5.18 Nektar Therapeutics Company Overview
5.18.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
5.19 Ology Bioservices Inc Company Overview
5.19.1 Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 OPKO Health Inc Company Overview
5.20.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 OtiTopic LLC Company Overview
5.21.1 OtiTopic LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Pharmaxis Ltd Company Overview
5.22.1 Pharmaxis Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 Quench Medical Inc Company Overview
5.23.1 Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Respira Therapeutics Inc Company Overview
5.24.1 Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sandoz International GmbH Company Overview
5.25.1 Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.26 Sheffield Hallam University Company Overview
5.26.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
5.27 Spyryx Biosciences Inc Company Overview
5.27.1 Spyryx Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sun Pharma Advanced Research Company Ltd Company Overview
5.28.1 Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Kansas Company Overview
5.29.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Sydney Company Overview
5.30.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Texas Medical Branch at Galveston Company Overview
5.31.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
5.32 Vectura Group Plc Company Overview
5.32.1 Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Verona Pharma Plc Company Overview
5.33.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Virginia Commonwealth University Company Overview
5.34.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview

6 Dry Powder Inhaler Devices- Recent Developments

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Table 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
Table 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
Table 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
Table 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials
Table 6: Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development
Table 7: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Table 8: Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Taper DPI - Product Status
Table 10: Taper DPI - Product Description
Table 11: Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: g60 Dry Powder Inhaler - Product Status
Table 13: g60 Dry Powder Inhaler - Product Description
Table 14: Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: resQhaler - Product Status
Table 16: resQhaler - Product Description
Table 17: AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Fentanyl TAIFUN Inhaler - Product Status
Table 19: Fentanyl TAIFUN Inhaler - Product Description
Table 20: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Duaklir Genuair Metered Dose Inhaler - Product Status
Table 22: Duaklir Genuair Metered Dose Inhaler - Product Description
Table 23: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Ciprofloxacin Dry Powder Inhaler - Product Status
Table 25: Ciprofloxacin Dry Powder Inhaler - Product Description
Table 26: Boehringer Ingelheim International GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Next Generation Respimat Inhaler - Product Status
Table 28: Next Generation Respimat Inhaler - Product Description
Table 29: Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Tiotropium bromide DPI - Product Status
Table 31: Tiotropium bromide DPI - Product Description
Table 32: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Intranasal Dry Powder Inhaler - Product Status
Table 34: Intranasal Dry Powder Inhaler - Product Description
Table 35: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Nasal Glucagon Delivery System - Product Status
Table 37: Nasal Glucagon Delivery System - Product Description
Table 38: GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Gemini Multi-Dose Combination Inhaler - Product Status
Table 40: Gemini Multi-Dose Combination Inhaler - Product Description
Table 41: Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Papillon DPI - Product Status
Table 43: Papillon DPI - Product Description

List of Figures

Figure 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development
Figure 2: Dry Powder Inhaler Devices - Pipeline Products by Territory
Figure 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path
Figure 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date
Figure 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

Adamis Pharmaceuticals Corp
Advent Pharmaceuticals Pty Ltd
Aespira Ltd.
AKELA Pharma Inc. (Inactive)
AstraZeneca Plc
Bayer AG
Boehringer Ingelheim International GmbH
Circassia Group Plc
Creare LLC
Eli Lilly and Co
GlaxoSmithKline Plc
Hovione Technology Ltd
Iconovo AB
Liquidia Technologies Inc
Lupin Pharmaceuticals Inc
MannKind Corp
Monash University
Nektar Therapeutics
Ology Bioservices Inc
OPKO Health Inc
OtiTopic LLC
Pharmaxis Ltd
Quench Medical Inc
Respira Therapeutics Inc
Sandoz International GmbH
Sheffield Hallam University
Spyryx Biosciences Inc
Sun Pharma Advanced Research Company Ltd
University of Kansas
University of Sydney
University of Texas Medical Branch at Galveston
Vectura Group Plc
Verona Pharma Plc
Virginia Commonwealth University

Note: Product cover images may vary from those shown

FEATURED COMPANIES

FEATURED COMPANIES

RELATED TAGS

RELATED PRODUCTS

Inhalers & Nebulizers Market Research Report by Product (Inhalers and Nebulizers), Indication, Distribution Mode, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

Dry Powder Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021

Metered Dose Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021

Global Smart Inhalers Market Size, Share & Industry Trends Analysis Report By Product, By Disease Indication, By Distribution Channel, By Regional Outlook and Forecast, 2021-2027

Digital Dose Inhalers - Global Market Trajectory & Analytics